Print Friendly, PDF & Email

NCT/Study#

NCT02601313 /

KTE-C19-102

A Phase 2 Multicenter Study Evaluating The Efficacy Of KTE-C19 In Subjects With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: